Perdrisot R - Search Results

1

Monoclonal immunoradiometric assay of calcitonin improves investigation of familial medullary thyroid carcinoma.

Perdrisot R, Bigorgne JC, Guilloteau D, Jallet P. Perdrisot R, et al. Clin Chem. 1990 Feb;36(2):381-3. Clin Chem. 1990. PMID: 2302785

2

Diagnosis of medullary carcinoma of the thyroid (MCT) by calcitonin assay using monoclonal antibodies: criteria for the pentagastrin stimulation test in hereditary MCT.

Guilloteau D, Perdrisot R, Calmettes C, Baulieu JL, Lecomte P, Kaphan G, Milhaud G, Besnard JC, Jallet P, Bigorgne JC. Guilloteau D, et al. Among authors: perdrisot r. J Clin Endocrinol Metab. 1990 Oct;71(4):1064-7. doi: 10.1210/jcem-71-4-1064. J Clin Endocrinol Metab. 1990. PMID: 2401708

3

[Chronic autoimmune thyroiditis and C-cell hyperplasia. Study of calcitonin secretion in 24 patients].

Barbot N, Guyetant S, Beldent V, Akrass A, Cerf I, Perdrisot R, Bigorgne JC. Barbot N, et al. Among authors: perdrisot r. Ann Endocrinol (Paris). 1991;52(2):109-12. Ann Endocrinol (Paris). 1991. PMID: 1929193 French.

4

[Low levels of TSH measured by a sensitive assay: do they reflect hyperthyroidism? A critical analysis of 580 cases].

Rohmer V, Ligeard-Ducoroy A, Perdrisot R, Beldent V, Jallet P, Bigorgne JC. Rohmer V, et al. Among authors: perdrisot r. Presse Med. 1990 May 12;19(19):897-900. Presse Med. 1990. PMID: 2141119 French.

5

[Detection of medullary cancer of the thyroid. Contribution of calcitonin determination by an immunoradiometric method using 2 monoclonal antibodies].

Bigorgne JC, Perdrisot R, Guilloteau D, Beldent V, Rohmer V, Jallet P. Bigorgne JC, et al. Among authors: perdrisot r. Presse Med. 1989 Oct 28;18(35):1754. Presse Med. 1989. PMID: 2531392 French. No abstract available.

6

Thyroid uptake of MIBG in Sipple's syndrome.

Perdrisot R, Rohmer V, Lejeune JJ, Bigorgne JC, Jallet P. Perdrisot R, et al. Eur J Nucl Med. 1988;14(1):37-8. doi: 10.1007/BF00252616. Eur J Nucl Med. 1988. PMID: 2898364

7

Four nonisotopic immunoassays of free thyroxin evaluated.

Perdrisot R, Bounaud MP, Bounaud JY, Jallet P. Perdrisot R, et al. Clin Chem. 1989 Jan;35(1):115-20. Clin Chem. 1989. PMID: 2910549

8

Radioiodinated meta-iodobenzylguanidine uptake in medullary thyroid cancer. A French cooperative study.

Baulieu JL, Guilloteau D, Delisle MJ, Perdrisot R, Gardet P, Delépine N, Baulieu F, Dupont JL, Talbot JN, Coutris G, et al. Baulieu JL, et al. Among authors: perdrisot r. Cancer. 1987 Nov 1;60(9):2189-94. doi: 10.1002/1097-0142(19871101)60:9<2189::aid-cncr2820600913>3.0.co;2-c. Cancer. 1987. PMID: 2894239

9

Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism.

Pouliquen D, Le Jeune JJ, Perdrisot R, Ermias A, Jallet P. Pouliquen D, et al. Among authors: perdrisot r. Magn Reson Imaging. 1991;9(3):275-83. doi: 10.1016/0730-725x(91)90412-f. Magn Reson Imaging. 1991. PMID: 1881245

10

Superparamagnetic iron oxide nanoparticles as a liver MRI contrast agent: contribution of microencapsulation to improved biodistribution.

Pouliquen D, Perdrisot R, Ermias A, Akoka S, Jallet P, Le Jeune JJ. Pouliquen D, et al. Among authors: perdrisot r. Magn Reson Imaging. 1989 Nov-Dec;7(6):619-27. doi: 10.1016/0730-725x(89)90530-4. Magn Reson Imaging. 1989. PMID: 2630844

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters